A detailed history of Quest Partners LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 2,202 shares of AGIO stock, worth $122,299. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,202
Previous 919 139.61%
Holding current value
$122,299
Previous $39.6 Million 146.89%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$41.19 - $49.72 $52,846 - $63,790
1,283 Added 139.61%
2,202 $97.8 Million
Q2 2024

Aug 06, 2024

BUY
$27.55 - $48.83 $25,318 - $44,874
919 New
919 $39.6 Million
Q4 2023

Feb 09, 2024

BUY
$19.97 - $24.53 $37,204 - $45,699
1,863 New
1,863 $41.5 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.04B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.